Infants' Tylenol oral suspension recalled

Share this article:

McNeil Consumer Healthcare is voluntarily recalling seven lots of Infants' Tylenol Oral Suspension, 1oz Grape, distributed nationwide in the U.S. after consumer complaints about difficulty using the SimpleMeasure dosing system.

The affected lots are:  IL0U00, BIL0V00, BIL3500, BJL2D00, BJL2E00, BJL2T00, BJL2U00; UPC Code: 300450122308.

SimpleMeasure includes a dosing syringe, which inserts into a protective cover or "flow restrictor," at the top of the bottle to measure the proper dose. In some cases, the flow restrictor was pushed into the bottle when inserting the syringe. If the flow restrictor is pushed into the bottle, the product should not be used.

Infants' Tylenol is an OTC product indicated as a pain reliever/fever reducer. Children's Tylenol products are intended for children two years of age and older and remain available.
Share this article:
You must be a registered member of Clinical Advisor to post a comment.

More in Web Exclusives

Self-monitoring, self-titrating hypertension meds benefit high-risk patients

Self-monitoring, self-titrating hypertension meds benefit high-risk patients

Coupling self-monitoring with self-titration of antihypertensives resulted in lower systolic blood pressure at 12 months, compared with usual care.

Obese kids more prone to bullying

Obese kids more prone to bullying

Obese and overweight children are more likely to be involved in bullying, both as victim and perpetrator.

Is medical marijuana reducing opioid overdose mortality?

Is medical marijuana reducing opioid overdose mortality?

States that have enacted medical cannabis laws have seen an overall 24.8% mean drop in state-level opioid overdose mortality rates.